Anti-Androgens

NICE Guidance (see also drug specific guidance below)

NG131: Prostate cancer: diagnosis and management, December 2021

  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary